Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Selvaraj Esthar"'
Autor:
Selvaraj Esthar, Jegathalaprathaban Rajesh, Natarajan Prakash, Srinivasan Ayyanaar, R. Bhaskar, Sundaram Thanigaivel, Thomas J. Webster, Gurusamy Rajagopal
Publikováno v:
Pharmacological Research - Modern Chinese Medicine, Vol 6, Iss , Pp 100219- (2023)
Introduction: The non-specific delivery of drugs to tissues is one of the major problems in traditional chemotherapy that creates problems, importantly cytotoxicity to healthy cells. A drug carrier can be designed and synthesized using a variety of t
Externí odkaz:
https://doaj.org/article/528b1ea248b0488b80271a171cdbf21c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Krishnamoorthy, Rajavenkatesh, Singh, Meenakshi, Anaikutti, Parthiban, Pavar, Mahesh Chand, Selvaraj, Esthar, Rajagopal, Saravanakumar, Vignesh, Rajendran Babhu
Publikováno v:
ChemistrySelect; Mar2024, Vol. 9 Issue 9, p1-11, 11p
Autor:
Selvaraj Esthar, Raman Dhivya, U. Ramesh, Jegathalaprathaban Rajesh, Thomas J. Webster, Jamespandi Annaraj, Guruswamy Rajagopal
Publikováno v:
Journal of Biomedical Nanotechnology. 18:2740-2749
One of the greatest benefits of nanomedicine elucidated to date includes the non-invasive tracking and monitoring of living organisms by the selective uptake of harmless metallic nanoparticles. Several nanoscale probes have been employed for biomolec
Autor:
Selvaraj Esthar, Jegathalaprathaban Rajesh, Srinivasan Ayyanaar, Gujuluva Gangatharan Vinoth Kumar, Sundaram Thanigaivel, Thomas J. Webster, Gurusamy Rajagopal
Publikováno v:
Materials Today Communications. 34:105365
Autor:
Selvaraj Esthar, Srinivasan Ayyanaar, Jegathalaprathaban Rajesh, M. Vadivel, R. Bhaskar, Gurusamy Rajagopal
Publikováno v:
Journal of Magnetism and Magnetic Materials. 546:168853
The major limitation of present cancer chemotherapeutic agents is the poor selectivity of anti-cancer drug and the resultant toxicity. To circumvent this limitation intense research is currently focused on development of controlled and targeted drug